Home -> Law Blog Directory -> Legal Research Blogs -> Slaw.ca
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Legal Research
: Slaw.caThis Week?s Biotech Highlights
By Jeremy Grushcow
Well, I can confirm that this past week conformed to my expectations for excitement, and not just because the Toronto garbage strike ended. In fact, confirmation was in the air:
- Most notably, the U.S. Senate confirmed three high-profile nominees: Sonia Sotomayor was confirmed as a U.S. Supreme Court justice, Francis Collins was confirmed as the director of NIH, and David Kappos was confirmed as the director of the U.S. Patent and Trademark Office.
- Two other U.S. developments confirmed the trend towards adoption of electronic medical records: 1) The President’s Council of Advisors on Science and Technology (PCAST) was meeting on health IT, and 2) The move towards a cloud computing approach to EMR marked by Salesforce.com?s investment in Practice Fusion.
- The Dow Jones Q2 venture capital data confirmed that things aren’t going very well for Canadian biotech and that government-backed funds need to step it up to get the industry back on its feet.
- An NCET2 webinar about MIT’s success in the area of entrepreneurship confirmed that literal tech transfer is only a small part of the picture and made several suggestions for other institutions hoping to encourage entrepreneurship.
Finally, Richard Chan confirmed that he has the chops to be the Cross-Border Biotech Blog’s new science writer. As I tweeted at the time, today’s Canadian science = tomorrow’s Canadian startups.
Full post as published by Slaw.ca on August 10, 2009 (boomark / email).
Bayer CropScience AG
alleging farmers suffered economic losses after Bayer's biotech Liberty Link rice was released into the food supply and countries banned US rice.

London Biotech week - Sept 22-26
BIO CEO Outlines Challenges for Obama Administration
ACI "Biotech Patents" Conference, Boston, September 15-16
Biotech Patents: How To Face New Challenges
What Can Biotech Do For You Just Ask.
Biotech/Pharma Lobbying Scoreboard - Third Quarter Update - Part II









